Concepedia

JoAnn Sigindere

JS

Statistics

Publications

3

Citations

49

H-Index

3

Active since

1992

Affiliations

Johnson & Johnson (United States)(Current)

JoAnn Sigindere is an author at Johnson & Johnson (United States) specializing in immunology, medicine, and cell biology.

Top concepts

Publications per year

1992–1994

3

Publications

3

7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine

Barbara L. Pope, JoAnn Sigindere, Erika Chourmouzis et al. · Cancer Immunology Immunotherapy · 1994 · 21 citations · Full text

, , +8

In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine)

Barbara L. Pope, Erika Chourmouzis, JoAnn Sigindere et al. · International Journal of Immunopharmacology · 1992 · 15 citations

, , +7

In Vivo Activation of Natural Killer Cells and Priming of IL-2 Responsive Cytolytic Cells by Loxoribine (7-Allyl-8-oxoguanosine)

Barbara L. Pope, Erika Chourmouzis, JoAnn Sigindere et al. · Cellular Immunology · 1993 · 13 citations

, , +9

1–3 of 3